Literature DB >> 10923288

Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation.

T S Girton1, T R Oegema, E D Grassl, B C Isenberg, R T Tranquillo.   

Abstract

We have recently reported that glycation can be exploited to increase the circumferential tensile stiffness and ultimate tensile strength of media-equivalents (MEs) and increase their resistance to collagenolytic degradation, all without loss of cell viability (Girton et al., 1999). The glycated MEs were fabricated by entrapping high passage adult rat aorta SMCs in collagen gel made from pepsin-digested bovine dermal collagen, and incubated for up to 10 weeks in complete medium with 30 mM ribose added. We report here on experiments showing that ME compaction due to traction exerted by the SMCs with consequent alignment of collagen fibrils was necessary to realize the glycation-mediated stiffening and strengthening, but that synthesis of extracellular matrix constituents by these cells likely contributed little, even when 50 micrograms/ml ascorbate was added to the medium. These glycated MEs exhibited a compliance similar to arteries, but possessed less tensile strength and much less burst strength. MEs fabricated with low rather than high passage adult rat aorta SMCs possessed almost ten times greater tensile strength, suggesting that alternative SMCs sources and biopolymer gels may yield sufficient strength by compositional remodeling prior to implantation in addition to the structural remodeling (i.e., circumferential alignment) already obtained.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923288     DOI: 10.1115/1.429652

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN: 0148-0731            Impact factor:   2.097


  27 in total

Review 1.  Designer blood vessels and therapeutic revascularization.

Authors:  Joseph D Berglund; Zorina S Galis
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

2.  Tissue constructs: platforms for basic research and drug discovery.

Authors:  Elliot L Elson; Guy M Genin
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

3.  Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels.

Authors:  Lan Yao; Jinyu Liu; Stelios T Andreadis
Journal:  Pharm Res       Date:  2007-12-19       Impact factor: 4.200

Review 4.  Review: advances in vascular tissue engineering using protein-based biomaterials.

Authors:  Jan P Stegemann; Stephanie N Kaszuba; Shaneen L Rowe
Journal:  Tissue Eng       Date:  2007-11

5.  Characterisation of a collagen membrane for its potential use in cardiovascular tissue engineering applications.

Authors:  E D O'Cearbhaill; V Barron; P E McHugh
Journal:  J Mater Sci Mater Med       Date:  2006-03       Impact factor: 3.896

6.  Generation, Endothelialization, and Microsurgical Suture Anastomosis of Strong 1-mm-Diameter Collagen Tubes.

Authors:  Xuanyue Li; Jing Xu; Calin T Nicolescu; Jordann T Marinelli; Joe Tien
Journal:  Tissue Eng Part A       Date:  2017-01-13       Impact factor: 3.845

7.  Crosslinked urethane doped polyester biphasic scaffolds: Potential for in vivo vascular tissue engineering.

Authors:  Jagannath Dey; Hao Xu; Kytai Truong Nguyen; Jian Yang
Journal:  J Biomed Mater Res A       Date:  2010-11       Impact factor: 4.396

Review 8.  Strategies for directing the structure and function of three-dimensional collagen biomaterials across length scales.

Authors:  B D Walters; J P Stegemann
Journal:  Acta Biomater       Date:  2013-09-06       Impact factor: 8.947

9.  Quantitative Multiscale Cell Imaging in Controlled 3D Microenvironments.

Authors:  Erik S Welf; Meghan K Driscoll; Kevin M Dean; Claudia Schäfer; Jun Chu; Michael W Davidson; Michael Z Lin; Gaudenz Danuser; Reto Fiolka
Journal:  Dev Cell       Date:  2016-02-22       Impact factor: 12.270

10.  Boundary stiffness regulates fibroblast behavior in collagen gels.

Authors:  Jeffrey John; Angela Throm Quinlan; Chiara Silvestri; Kristen Billiar
Journal:  Ann Biomed Eng       Date:  2009-12-10       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.